A developing area for PEDF in cancer is metabolomics analysis, as once we know which markers are upregulated or downregulated, researchers can attempt to focus and target specific metabolic pathways, even with changes in dietary habits, leading to tailor-made and personalised therapy. This evidence concerns the gene SERPINF1 and cancer.